130 results on '"Gosse, P"'
Search Results
2. First prospective multicentric registry on malignant hypertension: Rational, design and early results from 100 patients of the french HAMA cohort
3. When the worst is not that bad: Bordeaux protocol safety and efficacy in renovascular malignant hypertension
4. Beyond the PRES, a whole new entity: Cerebral impact of malignant hypertension
5. Therapeutic management of malignant hypertension: Proof of concept of an entirely oral therapeutic approach
6. Apport du 2D strain et des outils échocardiographiques classiques pour la recherche d’anomalies myocardiques induites par l’exposition chronique à un phéochromocytome
7. A NEW BREATH FOR MALIGNANT HYPERTENSION
8. SHORT-TERM BLOOD PRESSURE VARIABILITY AND CARDIOVASCULAR EVENTS
9. Un nouveau souffle pour l’Hypertension Artérielle MAligne : mise en place du registre national HAMA
10. Altération de la fonction systolique longitudinale du ventricule gauche en strain bidimensionnel dans l’hyperaldostéronisme primaire : un nouveau marqueur d’atteinte d’organe cible
11. NON-ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IS A MAJOR DETERMINANT OF THE CLINIC-AMBULATORY BP DIFFERENCE IN PATIENTS WITH RESISTANT HYPERTENSION
12. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial
13. [PP.17.12] LONG TERM VARIATIONS OF CREATININE IN ESSENTIAL HYPERTENSIVES
14. Primary aldosteronism and left ventricle in 2D echocardiography: new insights
15. [PP.25.13] PRIMARY ALDOSTERONISM AND LEFT VENTRICLE IN 2D ECHOCARDIOGRAPHY
16. [OP.1B.05] OVER-24H CENTRAL PULSE PRESSURE IS SUPERIOR TO PERIPHERAL PULSE PRESSURE FOR CARDIOVASCULAR EVENTS PREDICTION. RESULTS FROM THE BORDEAUX HYPERTENSIVE COHORT
17. [OP.4C.03] 24H BLOOD PRESSURE MONITORING TO PREDICT AND ASSESS IMPACT OF RENAL DENERVATION
18. [PP.25.08] IS ARTERIAL STIFFNESS EVALUATED BY PULSE WAVE VELOCITY PREDICTIVE OF THE IMPROVEMENT OF HYPERTENSION AFTER ADRENAL SURGERY FOR PRIMARY ALDOSTERONISM?
19. [PP.10.08] PRESENCE OF AORTIC ABDOMINAL CALCIFICATIONS IN PATIENTS WITH RESISTANT HYPERTENSION AND BP RESPONSE IN THE RENAL DENERVATION FOR HYPERTENSION (DENERHTN) TRIAL
20. Est-il utile de répéter les dosages de métanéphrines plasmatiques à quelques jours d’intervalle ?
21. [PP.35.04] MALIGNANT HYPERTENSION
22. Y a-t-il un intérêt à doser les métanephrines simultanément dans le plasma ET dans les urines ?
23. Sleep disruptions increase arterial stiffness
24. CO-08: Malignant hypertension: a french cohort study
25. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency
26. Diagnostic et traitement de l’hypertension artérielle maligne en réanimation. Réponse aux auteurs
27. 5A.05
28. PP.29.27
29. Coexistence of Vigorous Exercise and Heavy Smoking in Triggering Acute Myocardial Infarction in Men Under 35 Years — Fact or Fiction?
30. Angioplastie des sténoses athéromateuses de l’artère rénale: évolution de la tension artérielle et de la fonction rénale à long terme
31. High Frequency Records of Nutrients and Algal Biomass Pigments for Deciphering Biogeochemical Processes in the Loire River (France)
32. Malignant hypertension and interferon-beta: a case report
33. Caractéristiques cliniques, biochimiques, cellulaires et moléculaires des phéochromocytomes incidentaux
34. Mise en place et évaluation du dosage des métanéphrines plasmatiques dans un CHU
35. Atteinte des gros vaisseaux au cours de la sclérodermie systémique
36. Après Star et Astral, revenons sur terre !
37. Impairment of skin blood flow during post-occlusive reactive hyperhemy assessed by laser Doppler flowmetry correlates with renal resistive index
38. Metabolic Syndrome and Short-Term and Long-Term Heart Rate Variability in Elderly Free of Clinical Cardiovascular Disease: The PROOF Study
39. IMPAIRMENT OF SKIN BLOOD FLOW DURING PORH ASSESSED BY LASER DOPPLER FLOMETRY CORRELATES WITH RENAL RESISTIVE INDEX: PP.11.436
40. AVL R WAVE VOLTAGE DETERMINANTS IN NEVER TREATED HYPERTENSIVES: PP.35.453
41. CENTRAL SYSTOLIC BLOOD PRESSURE ESTIMATION BY NON INVASIVE HUMERAL SYSTOLIC BLOOD PRESSURE AND QKD INTERVAL: PP.3.124
42. Bénéfices tensionnels, anthropométriques et métaboliques de l’exérèse chirurgicale des adénomes cortisoliques infracliniques
43. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials
44. Preparation for surgery of phaeochromocytoma by blockade of α-adrenergic receptors with urapidil: what dose?
45. Magnitude of the early morning blood pressure surge in untreated hypertensive patients: a pooled analysis
46. Regression of Left Ventricular Hypertrophy: Should We Echo Echo?
47. Response to "Spotlights on Ambulatory Measures of Arterial Stiffness"
48. Hypertrophie ventriculaire gauche au cours de l'hypertension artérielle
49. Can Ambulatory Blood-Pressure Monitoring Provide Reliable Indices of Arterial Stiffness?
50. Does eplerenone have a future in the management of hypertension in Europe?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.